Person profile
Address
Burlington, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Pacira BioSciences, Inc.
13 Jun 24
4
Rapport Therapeutics, Inc.
10 Jun 24
3
Rapport Therapeutics, Inc.
6 Jun 24
4
Pacira BioSciences, Inc.
11 Oct 23
3
Pacira BioSciences, Inc.
11 Oct 23
144/A
Cerevel Therapeutics Holdings, Inc.
8 May 23
144
Cerevel Therapeutics Holdings, Inc.
8 May 23
144
Cerevel Therapeutics Holdings, Inc.
5 May 23
144
Cerevel Therapeutics Holdings, Inc.
4 May 23
4
Cerevel Therapeutics Holdings, Inc.
8 Feb 23
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 12 Jun 24 | PCRX Pacira BioSciences | Common Stock | Grant | Acquire A | No | No | 0 | 5,230 | 0.00 | 5,230 |
| 12 Jun 24 | PCRX Pacira BioSciences | Stock Option Common Stock | Grant | Acquire A | No | No | 28.68 | 12,179 | 349.29 k | 12,179 |
| 6 Jun 24 | RAPP Rapport Therapeutics, Inc. Common Stock | Stock Option Common Stock | Grant | Acquire A | No | No | 17 | 530,647 | 9.02 mm | 530,647 |
| 6 Oct 23 | PCRX Pacira BioSciences | Stock Option Common Stock | Grant | Acquire A | No | No | 29.8 | 30,967 | 922.82 k | 30,967 |